Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Anticancer Research|July 15, 2009
Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancerGoro Matsuda, Chikara Kunisaki, Hirochika Makino, et al.Anticancer Research|July 24, 2010
Indication for hepatic resection in the treatment of liver metastasis from gastric cancerHirochika Makino, Chikara Kunisaki, Yusuke Izumisawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Stage IV Gastric Cancer Successfully Treated Using Salvage Surgery after S-1/CDDP Therapy]Yuko Shimada, Tsutomu Hayashi, Keisuke Minamizawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[A Case of Resected Gastric Cancer Invading the Esophagus with Esophageal Recurrence That Responded to Weekly Docetaxel／Cisplatin Chemotherapy]Yukio Maezawa, Tsutomu Hayashi, Jun Yamamoto, et al.Cancer Science|November 21, 2012
High expression of KIBRA in low atypical protein kinase C-expressing gastric cancer correlates with lymphatic invasion and poor prognosisYohei Yoshihama, Yusuke Izumisawa, Kazunori Akimoto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[The Case of HER2 Positive Advanced Gastric Cancer with Para-Aorta Lymph Node Recurrence Responding to Capecitabine plus CDDP plus Trastuzumab Chemotherapy]Itaru Hashimoto, Hitoshi Murakami, Sayaka Arisaka, et al.Anticancer Research|July 31, 2014
Macroscopic type is a prognostic factor for recurrence-free survival after resection of gastric GISTHiroshi Miyamoto, Chikara Kunisaki, Yuichi Otsuka, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 22, 2007
Impact of splenectomy in patients with gastric adenocarcinoma of the cardiaChikara Kunisaki, Hirochika Makino, Hirokazu Suwa, et al.Cancer Chemotherapy and Pharmacology|September 16, 2017
Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107Kei Sato, Chikara Kunisaki, Takashi Kosaka, et al.Anticancer Research|December 4, 2018
A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric CancerSho Sato, Chikara Kunisaki, Yusaku Tanaka, et al.Pageof 7